» Authors » Yogita Ghodke

Yogita Ghodke

Explore the profile of Yogita Ghodke including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 173
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghodke Y, Anderson P, Sangkuhl K, Lamba J, Altman R, Klein T
Pharmacogenet Genomics . 2012 Sep; 22(12):891-4. PMID: 22960662
No abstract available.
2.
Joshi K, Ghodke Y, Shintre P
J Ayurveda Integr Med . 2011 Aug; 1(1):26-32. PMID: 21829298
'Omics' developments in the form of genomics, proteomics and metabolomics have increased the impetus of traditional medicine research. Studies exploring the genomic, proteomic and metabolomic basis of human constitutional types...
3.
Mitra A, Crews K, Pounds S, Cao X, Feldberg T, Ghodke Y, et al.
J Pharmacol Exp Ther . 2011 Jun; 339(1):9-23. PMID: 21712425
Cytosolic 5'-nucleotidase II (NT5C2) is involved in the development of 1-β-d-arabinofuranosylcytosine (ara-C) resistance and has been associated with clinical outcome in patients receiving ara-C-based chemotherapy. NT5C2 inactivates ara-C by dephosphorylating...
4.
Ghodke Y, Chopra A, Shintre P, Puranik A, Joshi K, Patwardhan B
Indian J Med Res . 2011 Mar; 133:274-9. PMID: 21441680
Background & Objectives: Many pharmacologically-relevant polymorphisms show variability among different populations. Though limited, data from Caucasian subjects have reported several single nucleotide polymorphism (SNPs) in folate biosynthetic pathway. These SNPs...
5.
Ghodke Y, Joshi K, Patwardhan B
Evid Based Complement Alternat Med . 2009 Dec; 2011:249528. PMID: 20015960
Traditional Indian medicine-Ayurveda-classifies the human population into three major constituents or Prakriti known as Vata, Pitta and Kapha types. Earlier, we have demonstrated a proof of concept to support genetic...
6.
Ghodke Y, Chopra A, Joshi K, Patwardhan B
Clin Rheumatol . 2008 Feb; 27(6):787-9. PMID: 18274813
Methotrexate (MTX) is among the best-tolerated disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis (RA); major drawbacks of MTX therapy are the large interpatient variability in clinical response and...
7.
Ghodke Y, Joshi K, Arya Y, Radkar A, Chiplunkar A, Shintre P, et al.
Eur J Epidemiol . 2007 Nov; 22(12):907-15. PMID: 17978853
Inter-individual variability in drug response is well known. Genetic polymorphism in genes encoding drug-metabolizing enzymes results in variation in drug metabolism and in turn drug response. The cytochrome P450 enzymes...
8.
Ghodke Y, Joshi K, Chopra A, Patwardhan B
Eur J Epidemiol . 2005 Aug; 20(6):475-88. PMID: 16121756
Association of HLA and diseases is well known. Several population studies are available suggesting evidence of association of HLAs in more than 40 diseases. HLA found across various populations vary...